Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | MGLL | Q99685 | 3/20 | 0.39 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | PCNA | P12004 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18883201 | 0.93 | ALDH1A1 (0.72) | ALDH1A1TSHRMAPK1SMN1; SMN2HRH3 | |
| SCHEMBL10884364 | 0.87 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1SMN1; SMN2HRH3 | |
| SCHEMBL10458541 | 0.87 | ALDH1A1 (0.67) | ALDH1A1TSHRMAPK1SMN1; SMN2HRH3 | |
| SCHEMBL10889886 | 0.87 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1SMN1; SMN2HRH3 | |
| SCHEMBL10458813 | 0.87 | ALDH1A1 (0.67) | ALDH1A1TSHRMAPK1SMN1; SMN2HRH3 | |
| SCHEMBL18883164 | 0.86 | ALDH1A1 (0.67) | ALDH1A1TSHRMAPK1SMN1; SMN2HRH3 | |
| SCHEMBL9291268 | 0.84 | ALDH1A1 (0.70) | ALDH1A1TSHRMAPK1SMN1; SMN2HRH3 | |
| SCHEMBL9679529 | 0.82 | SMN1; SMN2 (0.72) | ALDH1A1TSHRMAPK1SMN1; SMN2HRH3 | |
| SCHEMBL1554443 | 0.82 | ALDH1A1 (0.72) | ALDH1A1TSHRMAPK1SMN1; SMN2HRH3 | |
| SCHEMBL1553588 | 0.82 | ALDH1A1 (0.72) | ALDH1A1TSHRMAPK1SMN1; SMN2HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10005851-B2 | Polymerization initiator and radically polymerizable composition containing same | ADEKA CORPORATION (JP) | 2018-06-26 | — | — | US | disclosed |
| US-10005851-B2 | Polymerization initiator and radically polymerizable composition containing same | ADEKA CORPORATION (JP) | 2018-06-26 | — | — | US | disclosed |
| US-20170145121-A1 | NOVEL POLYMERIZATION INITIATOR AND RADICALLY POLYMERIZABLE COMPOSITION CONTAINING SAME | ADEKA CORPORATION (JP) | 2017-05-25 | — | — | US | disclosed |
| US-20170145121-A1 | NOVEL POLYMERIZATION INITIATOR AND RADICALLY POLYMERIZABLE COMPOSITION CONTAINING SAME | ADEKA CORPORATION (JP) | 2017-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170145121-A1 | NOVEL POLYMERIZATION INITIATOR AND RADICALLY POLYMERIZABLE COMPOSITION CONTAINING SAME | CYBA, CCNT1, CCNA1 | ALDH1A1 269/4885TSHR 4773/4885MAPK1 540/4885 |
| US-10005851-B2 | Polymerization initiator and radically polymerizable composition containing same | CYBA, CCNT1, SPTBN1 | ALDH1A1 165/4885TSHR 4808/4885MAPK1 585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.